Login to Your Account

CRO Semler smacked with WHO, FDA letters citing data manipulation

By T.V. Padma and Cornelia Zou
Staff Writers

Friday, April 29, 2016

HYDERABAD, India – A number of drug companies in India may have to repeat expensive clinical trials after Bangalore-based CRO Semler Research Center Pvt. Ltd. received warnings from both the WHO and the FDA in April over data manipulation.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription